Global Cord Blood Corp
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation… Read more
Global Cord Blood Corp (CORBF) - Total Assets
Latest total assets as of June 2022: $1.35 Billion USD
Based on the latest financial reports, Global Cord Blood Corp (CORBF) holds total assets worth $1.35 Billion USD as of June 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Global Cord Blood Corp - Total Assets Trend (2007–2022)
This chart illustrates how Global Cord Blood Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Global Cord Blood Corp - Asset Composition Analysis
Current Asset Composition (March 2022)
Global Cord Blood Corp's total assets of $1.35 Billion consist of 81.3% current assets and 18.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $6.66 Billion | 78.1% |
| Accounts Receivable | $161.30 Million | 1.9% |
| Inventory | $45.88 Million | 0.5% |
| Property, Plant & Equipment | $476.69 Million | 5.6% |
| Intangible Assets | $83.58 Million | 1.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2022)
This chart illustrates how Global Cord Blood Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Global Cord Blood Corp's current assets represent 81.3% of total assets in 2022, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 78.1% of total assets in 2022, down from 99.9% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
- Asset Diversification: The largest asset category is cash and equivalents at 78.1% of total assets.
Global Cord Blood Corp Competitors by Total Assets
Key competitors of Global Cord Blood Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Global Cord Blood Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Global Cord Blood Corp generates 0.15x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Global Cord Blood Corp generates $5.87 in net profit.
Global Cord Blood Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.73 | 10.05 | 8.14 |
| Quick Ratio | 10.66 | 9.99 | 8.06 |
| Cash Ratio | 0.00 | 9.68 | 0.00 |
| Working Capital | $991.98 Million | $ 5.83 Billion | $ 3.60 Billion |
Global Cord Blood Corp - Advanced Valuation Insights
This section examines the relationship between Global Cord Blood Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.24 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 7.9% |
| Total Assets | $8.53 Billion |
| Market Capitalization | $134.00 Million USD |
Valuation Analysis
Below Book Valuation: The market values Global Cord Blood Corp's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Global Cord Blood Corp's assets grew by 7.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Global Cord Blood Corp (2007–2022)
The table below shows the annual total assets of Global Cord Blood Corp from 2007 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-03-31 | $8.53 Billion | +7.95% |
| 2021-03-31 | $7.91 Billion | +9.51% |
| 2020-03-31 | $7.22 Billion | +10.21% |
| 2019-03-31 | $6.55 Billion | +12.09% |
| 2018-03-31 | $5.84 Billion | +12.76% |
| 2017-03-31 | $5.18 Billion | +10.56% |
| 2016-03-31 | $4.69 Billion | +13.80% |
| 2015-03-31 | $4.12 Billion | +13.45% |
| 2014-03-31 | $3.63 Billion | +21.59% |
| 2013-03-31 | $2.99 Billion | +63.71% |
| 2012-03-31 | $1.82 Billion | +16.66% |
| 2011-03-31 | $1.56 Billion | +49.34% |
| 2010-03-31 | $1.05 Billion | +431.51% |
| 2009-03-31 | $196.99 Million | -21.11% |
| 2008-03-31 | $249.70 Million | -5.06% |
| 2007-03-31 | $262.99 Million | -- |